These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 21934577)

  • 1. Utility of antimicrobial susceptibility testing in Trichomonas vaginalis-infected women with clinical treatment failure.
    Bosserman EA; Helms DJ; Mosure DJ; Secor WE; Workowski KA
    Sex Transm Dis; 2011 Oct; 38(10):983-7. PubMed ID: 21934577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
    Seña AC; Bachmann LH; Hobbs MM
    Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
    Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
    Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistant trichomoniasis: successful treatment with combination therapy.
    Nyirjesy P; Gilbert J; Mulcahy LJ
    Sex Transm Dis; 2011 Oct; 38(10):962-3. PubMed ID: 21934573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The presence of dsRNA virus in Trichomonas vaginalis isolates from symptomatic and asymptomatic Indian women and its correlation with in vitro metronidazole sensitivity.
    Malla N; Kaul P; Sehgal R; Gupta I
    Indian J Med Microbiol; 2011; 29(2):152-7. PubMed ID: 21654110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of trichomonas vaginalis in women with suspected metronidazole hypersensitivity.
    Helms DJ; Mosure DJ; Secor WE; Workowski KA
    Am J Obstet Gynecol; 2008 Apr; 198(4):370.e1-7. PubMed ID: 18221927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis.
    Sobel JD; Nyirjesy P; Brown W
    Clin Infect Dis; 2001 Oct; 33(8):1341-6. PubMed ID: 11565074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of metronidazole-resistant Trichomonas vaginalis--a new approach.
    Mammen-Tobin A; Wilson JD
    Int J STD AIDS; 2005 Jul; 16(7):488-90. PubMed ID: 16004628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of metronidazole-resistant Trichomonas vaginalis in pregnancy.
    Forbes GL; Drayton R; Forbes GD
    Int J STD AIDS; 2016 Sep; 27(10):906-8. PubMed ID: 26384945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population.
    Abdel-Magied AA; El-Kholya EI; Abou El-Khair SM; Abdelmegeed ES; Hamoudaa MM; Mohamed SA; El-Tantawy NL
    Parasitol Res; 2017 Nov; 116(11):3125-3130. PubMed ID: 28956167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic.
    Schmid G; Narcisi E; Mosure D; Secor WE; Higgins J; Moreno H
    J Reprod Med; 2001 Jun; 46(6):545-9. PubMed ID: 11441678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Testing of Trichomonas vaginalis Drug Susceptibility: Evaluation of Minimal Lethal Concentrations for Metronidazole and Tinidazole That Correspond With Treatment Failure.
    Augostini P; Bradley ELP; Raphael BH; Secor WE
    Sex Transm Dis; 2023 Jun; 50(6):370-373. PubMed ID: 36849257
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Ghosh AP; Aycock C; Schwebke JR
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29439963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of metronidazole-resistant Trichomonas vaginalis.
    Goldman LM; Upcroft JA; Workowski K; Rapkin A
    Sex Health; 2009 Dec; 6(4):345-7. PubMed ID: 19917205
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Mtshali A; Ngcapu S; Govender K; Sturm AW; Moodley P; Joubert BC
    Microbiol Spectr; 2022 Aug; 10(4):e0091222. PubMed ID: 35863010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonoxynol 9 as an additive therapy in metronidazole-resistant cases of vaginal trichomoniasis.
    El Bassiouni SO; Riad RM
    J Egypt Soc Parasitol; 2005 Aug; 35(2):551-62. PubMed ID: 16083067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological variability of Trichomonas vaginalis clinical isolates from symptomatic and asymptomatic patients.
    Hussien EM; El-Sayed HZ; Shaban MM; Salm AM; Rashwan M
    J Egypt Soc Parasitol; 2004 Dec; 34(3):979-88. PubMed ID: 15587322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycoplasma hominis infection of Trichomonas vaginalis is not associated with metronidazole-resistant trichomoniasis in clinical isolates from the United States.
    Butler SE; Augostini P; Secor WE
    Parasitol Res; 2010 Sep; 107(4):1023-7. PubMed ID: 20652315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro studies of tinidazole in Trichomonas vaginalis infection.
    Sucharit P; Uthaischant A; Chintana T; Suphadtanapongs W; Eamsobhana P; Prasomsitti P
    Southeast Asian J Trop Med Public Health; 1979 Dec; 10(4):556-61. PubMed ID: 317171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trichomoniasis and its treatment.
    Nanda N; Michel RG; Kurdgelashvili G; Wendel KA
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):125-35. PubMed ID: 16441214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.